Previous 10 | Next 10 |
A recent Canadian study has suggested that psilocybin, the main hallucinogenic agent in magic mushrooms, may ease the psychological distress associated with childhood trauma. Researchers say the psychedelic seemed to offer “particularly strong benefits” to individuals who faced ex...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, ...
– 53 participants enrolled across two sites – Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...
Recent study findings published in the “Substance Use & Misuse” journal indicate that the use of psychedelics such as LSD is becoming especially prevalent among business managers in managerial positions. The study found that while there has been a general increase in psychedel...
2023-10-18 07:48:55 ET Companies mentioned in this editorial; Lucy Scientific Discovery Inc. (NASDAQ: LSDI), Compass Pathways (NASDAQ: CMPS), Mind Medicine Inc (NASDAQ: MNMD), Overstock.com Inc. (NADAQ: OSTK), and Constellation Brands (NYSE: STZ) and Canopy Growth (NYSE: CGC). DENVER, C...
Psychedelics are poised to transform the mental-health landscape in a way conventional mental-health treatments have failed to achieve. Recent research into the potential benefits and risks of psychedelics has uncovered significant evidence of their therapeutic effectiveness against a wide variet...
2023-10-13 18:37:35 ET Summary Results from the phase 2b study, using MM-120 for the treatment of patients with generalized anxiety disorder, expected Q4 of 2023. The Generalized Anxiety Disorder market is set to reach $7.4 billion in 2023. Results from phase 2a proof-of-conce...
Governor Gavin Newsom of California has vetoed a measure that would legalize a number of psychedelics and establish a pathway for regulated access. In his message regarding the veto, the governor urged the legislature to present a new resolution in 2024 that created guidelines for regulated ac...
Psychedelics have taken over the mainstream public’s attention in recent years due to increasing reports on their potential mental-health benefits . A growing body of scientific literature has found that psychedelics may be effective at treating a plethora of mental-health conditions at s...
– Preclinical data in ASD model demonstrate the differences between MM-402 (R-MDMA), S-MDMA and Racemic MDMA with enhanced pro-social effects and reduced hyperactivity – Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “Mi...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...